AXATILIMAB vs VIMSELTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
AXATILIMAB vs VIMSELTINIB: Safety Overview
| Metric | AXATILIMAB | VIMSELTINIB |
|---|---|---|
| Total FAERS Reports | 16 | 170 |
| Deaths Reported | 2 | 0 |
| Death Rate | 12.5% | N/A |
| Hospitalizations | 13 | 5 |
| Average Patient Age | 39.6 yrs | 45.6 yrs |
| % Female Patients | 61.1% | 55.4% |
| FDA Approval Date | N/A | Feb 14, 2025 |
| Manufacturer | Incyte Corporation | Deciphera Pharmaceuticals, LLC |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Prescription |